Central pontine myelinolysis
* Not a rare disease
Other Names for this Disease
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
Unfortunately, there is no treatment of choice for central pontine myelinolysis. Four treatments have been tried in a small number of patients with encouraging results; however, these are experimental and none has been proven effective by a clinical trial. The four experimental treatments include plasmapheresis, which is a procedure that attempts to remove toxic substances from the blood; thyrotropin-releasing hormone (TRH), which may help damaged tissues in the brain by increasing the blood supply to these areas; corticosteriods, which are medications that may suppress potentially harmful immune responses; or immunoglobulin therapy, which is also thought to remove toxic substances from the blood.  Supportive therapy to address the symptoms of this condition include physical therapies and rehabilitation.
Last updated: 7/21/2011
- Lampl C, Yazdi K. Central pontine myelinolysis. European neurology. 2002; 47:3-10. http://www.ncbi.nlm.nih.gov/pubmed/11803185. Accessed 7/20/2011.
- Central Pontine Myelinolysis Information Page. The National Institute of Neurological Disorders and Stroke. September 22, 2010; http://www.ninds.nih.gov/disorders/central_pontine/central_pontine_myelinolysis.htm. Accessed 9/22/2010.
- Finding Treatment Information - A video developed by GARD Information Specialists that explains how you can find information about treatment for a rare disease.